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Summary  
The specifidty of antibody (Ab) responses depends on focusing helper T (Th) lymphocyte signals 
to suitable B lymphocytes capable of binding foreign antigens (Ags), and away from nonspecific 
or self-reactive B cells. To investigate the molecular mechanisms that prevent he activation of 
self-reactive B lymphocytes, the activation requirements of B cells specific for the Ag hen egg 
lysozyme (HEL) obtained from immunoglobulin (Ig)-transgenic mice were compared with those 
of functionally tolerant B cells isolated from Ig-transgenic mice which also express soluble HEL. 
To eliminate the need for surface (s)Ig-mediated Ag uptake and presentation and allow the effects 
of slg signaling to be studied in isolation, we assessed the ability of allogeneic T cells from bm12 
strain mice to provide in vivo help to C57BL/6 strain-transgenic B ells. Interestingly, non- 
tolerant Ig-transgenic B cells required both allogeneic Th cells and binding of soluble HEL for 
efl~dent activation and Ab production. By contrast, tolerant self-reactive B cells from Ig/HEL 
double transgenic mice responded poorly to the same combination ofallogeneic T cells and soluble 
HEL. The tolerant B cells were nevertheless normally responsive to stimulation with interleukin 
4 and anti-CD40 Abs in vitro, suggesting that they retained the capacity to respond to mediators 
of T cell help. However, the tolerant B cells exhibited a proximal block in the slg signaling 
pathway which prevented activation of receptor-assodated yrosine kinases in response to the 
binding of soluble HEL. The functional significance of this slg signaling defect was confirmed 
by using a more potent membrane-bound form of HEL capable of triggering slg signaling in 
tolerant B cells, which markedly restored their ability to collaborate with allogeneic Th cells 
and produce Ab. These findings indicate that Ag-specific B cells require two signals for mounting 
a T cell-dependent Ab response and identify regulation of slg signaling as a mechanism for con- 
trolling self-reactive B cells. 
T he ability to distinguish between self and foreign Ags is a central feature of immune recognition, allowing im- 
munity to be acquired against foreign organisms while 
avoiding destructive autoimmunity. Studies of self-nonself 
discrimination i  recent years (for reviews ee references 1-3) 
have confirmed the clonal selection theory proposed by Bumet 
(4), which hypothesized that foreign Ags provoke immunity 
by triggering clonal expansion and differentiation of Ag- 
binding B and T lymphocytes, whereas elf-Ags induce toler- 
ance by triggering elimination or inactivation of self-reactive 
cells. Although these advances provide a cellular framework 
for understanding self-nonselfdiscrimination, he molecular 
mechanisms that dictate the choice between lymphocyte ac- 
tivation or tolerance neverthdess remain to be defined. Un- 
derstanding the molecular basis for these cellular decisions 
will be important for controlling the immunogenicity or 
tolerogenicity of vaccines, tumors, and tissue transplants, and 
for understanding the breakdown of stir-tolerance in auto- 
immune diseases. 
The decision between lymphocyte activation and tolerance 
seems particularly approachable in B lymphocytes, since much 
is already known about the cellular and molecular events 
causing B cells to proliferate and differentiate into Ab-secreting 
plasma cells in response to foreign Ags. For many foreign 
Ags, Th cells play a key role in promoting B cell prolifera- 
tion and Ab production, by adhering to suitable B cells and 
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transmitting a set of B cell growth and differentiation signals. 
One of the most important signals is an integral membrane 
protein, CD40-1igand (CD40L) 1, that is transiently dis- 
played on the surface of activated Th cells and triggers B cell 
proliferation through a receptor, CD40, constitutively ex- 
pressed on B cells (5, 6). Other molecules ecreted by acti- 
vated Th cells, such as IL-4 and -10, synergize with CD40L 
in promoting B cell proliferation and in triggering isotype 
switching and differentiation i to plasma cells (for a recent 
review see reference 7). 
Since the receptors for CD40L, IL-4, and IL-IO are con- 
stitutively expressed on all B cells, development of an effec- 
tive Ab response depends on preferential delivery of these helper 
signals to useful B cells whose surface Ig (sIg) bind foreign 
Ag, and not to useless B calls that do not bind Ag or to 
potentially harmful B cells that bind sdf-Ags. The specificity 
of T cell help is directed, at least in part, by the requirement 
that Th cells recognize acomplex composed of foreign Ag 
peptide fragments and class II MHC molecules, that is dis- 
played on the surface of potential B cell targets (8-12). Rec- 
ognition of peptide-MHC complexes by the TCR strengthens 
the interaction between T and B cells (13), triggers CD40L 
expression (6, 14), and polarizes IL secretion to the point 
of synapsis between T and B cells (15, 16). Since B cells that 
bind foreign Ags are more efficient at internalizi,ng these Ags 
than other nonbinding B cells, Ag-specific B cells are most 
likely to present foreign peptide fragments and trigger delivery 
of T cell help (for a review see reference 12). Other receptor/ 
ligand pairs also contribute to the synapsis of T and B cells, 
such as the binding of LFA-1 on both T and B cell to inter- 
cellular adhesion molecule 1(ICAM-1) on the opposing cell 
(13, 17, 18) or the binding of CD28 on the T cell to B7 
on the B cell (19), but their role in guiding the specificity 
of T-B cell interaction is not known. 
The molecular mechanisms responsible for B cell tolerance 
are not well understood, especially in situations where self- 
reactive B cells become functionally inactivated (anergic) but 
are not physically eliminated. In this paper, we have explored 
the basis for tolerance in anergic self-reactive B cells by using 
a model developed previously (20) in which Ig gene trans- 
genic mice, whose B lymphocytes express urface IgM and 
IgD specific for the Ag hen-egg lysozyme (HEL), were mated 
with transgenic mice expressing the soluble form of HEL. 
In the resulting soluble lysozyme/anti-lysozyme double (Dbl)- 
transgenic mice, self-reactive anti-lysozyme B cells developed 
normally and populated the peripheral lymphoid organs but 
were functionally tolerant o lysozyme. Since the tolerant B
cells were present in normal numbers and expressed all of 
the developmentally regulated cell surface molecules thought 
to contribute to B cell activation, the explanation for toler- 
ance was obscure. Here, we describe that tolerant B cells from 
these mice remain responsive to T cell-derived signals, but 
1Abbr~tions used in this pat~': CD4OL, CD40-ligand; Dbl, double; HEL. 
hen-egg lysozyme; ICAM-I, intercellular adhesion molecule 1;slg, sur- 
face Ig; SA-PE, streptavidin-PE. 
exhibit a proximal block in B cell slg signaling after Ag binding 
that precludes effective collaboration with T cells. Moreover, 
the sIg signaling block can be partially overcome by very ex- 
tensive receptor cross-linking, and this markedly restored col- 
laboration with Th cells. These findings demonstrate a piv- 
otal role for sIg signaling in guiding T cell-dependent Ab 
responses and that regulation of sIg signaling provides amech- 
anism for controlling self-reactive B cells. 
Materials and Methods 
Mice. Anti-HEL/sHEL Dbl-transgenic animals were obtained 
by mating transgenic animals from the MD4 anti-HEL IgM + 
IgD line and the ML5 soluble HEL line, which were produced 
and maintained on a C57BL/6J (B6) background as described (20). 
To mark the Ig- or Dbl-transgenic cells with Ly5 ~, B6 MD4 x 
ML5 Dbl-transgenic mice were mated with C57BL/6-Ly5" con- 
genic mice (the generous gift of Dr. I. Weissman, Stanford Univer- 
sity, Stanford, CA), and the Ft-hybrid offspring used as spleen cell 
donors. Membrane (m)HEL transgenic mice were from the line 
KLK4 expressing lysozyme fused to class I transmembrane d cy- 
toplasmic regions (21). B6 and bin12 mice were obtained from The 
Jackson Laboratory (Bar Harbor, ME). All mice used were between 
8 and 16 wk of age. 
Adoptive Transfers. Recipient mice were age matched or litter- 
mate C57BL/6J nontransgenic, sHEL transgenic (ML5 line), or 
mHEL transgenic (KLK4 line) mice, sublethally irradiated with 
750 tad x-irradiation and injected intravenously with 107 trans- 
genic splenocytes and 5 x 107 splenocytes from B6 or bm12 mice. 
Cotransfer experiments (e.g., see Fig. 2, A-C) used the same pro- 
tocol except that 107 B6-Dbl-transgenic splenocytes were injected 
along with 107 Ig/Ly5' splenocytes and 5 x 107 splenocytes from 
B6 or bin12 mice. 5 d after transfer, spleen cells from the recipients 
were harvested, counted by hemocytometer, stained for FACS| - 
),sis as described below, and the number of anti-HEL IgM' Ab- 
secreting cells enumerated by spot ELISA (22). 
In Vitro Cultures. For MLCs (see Fig. 2 D), 10 s Ly5~-bearing 
splenocytes from either lg-, Dbl-, or non-transgenic mice were cul- 
tured with 5 x 10 s splenocytes from B6 mice and 5 x 100 spleno- 
cytes from bm12 mice. Cells were cultured in round-bottomed 96- 
well plates (Falcon) at 37"C, in 5% CO2 in 0.2 ml of RPMI 
media supplemented with 10% FCS, 2 mM glutamine, 50/zM 2- 
MEK, with or without 100 ng/ml HEL (Sigma Chemical Co., 
St. Louis, MO). After 4 d of culture, cells were washed free of 
residual HEL and the number of anti-HEL IgM ~ secreting cells 
determined by spot ELISA. For LPS stimulation, 20/zg/ml LPS 
(Escherichia coli 0111:B4; Difco Laboratories, Detroit, MI) was added 
to parallel cultures containing 10 s Ig- or Dbl-transgenic spleen 
cells. Proliferation assays used 10 s splenocytes cultured in flat- 
bottomed 96-well plates (Linbro) in a final volume of 0.1 ml RPMI 
media (see Fig. 3) or 0.2 ml (see Figs. 4 and 6) supplemented with 
the indicated concentrations of rat antisera to recombinant extracel- 
luhr domain of mouse CD40 (Heath, A., W. Wu, and M. Howard, 
manuscript submitted for publication), HEL, LPS, recombinant 
mouse I1.-4 (DNAX), polydonal goat anti-mouse IgD Ab (23), 
or ionomycin (Calbiochem-Novabiochem Corp., LaJolla, CA) and 
PMA (Sigma Chemical Co.). To assess proliferative r sponses to
ionomycin and PMA, splenocytes were depleted of T cells using 
sheep anti-FITC coated magnetic bea__ds (Advanced Magnetics, Cam- 
bridge, MA) after staining with FITC-conjugated Abs to CD4 
(clone GK1.5, Becton Dickinson & Co., Mountain View, CA) and 
CD8 (clone TYS169.4, Becton Dickinson & Co.). T cell-depleted 
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splenocytes contained (1% CD4- or CD8-positive cells. Prolifer- 
ating cells were detected by a 12-16 h pulse with [3H]thymidine 
48 h after stimulation as described (24). [3H]uridine incorporation 
was determined by pulsing cells from 0-24 h of culture with 1 
/zCi/well [3H]uridine (Amersham Corp., Arlington Heights, IL) 
and harvesting the cells for scintillation counting. Values represent 
the means of triplicate determinations. For FACS | analysis (Becton 
Dickinson & Co.) of stimulated cells, splenocytes from Ig or Dbl- 
transgenic mice were cultured at 106/ml in 1 ml for 12 or 24 h 
at 37~ in medium alone or with rlL-4 (100 U/ml), anti-CD40 
(final dilution 1:104), lysozyme (100 ng/ml), or goat anti-IgD (10 
/zg/ml). 
Flow Cytoraetry Staining and Analysis. Cell staining and three- 
color FACS | analysis were conducted as described (25). Ly5 ~ was 
detected using FITC-conjugated AS20 (25) and HEL-binding cells 
were revealed by incubating with 100 ng/ml HEL followed by 
HyHEL5-biotin and streptavidin-Tricolor (Caltag Laboratories, San 
Francisco, CA) as described (25). Syndecan was detected with mAb 
284.1 (26) followed by F(ab)2 anti-rat IgG conjugated to PE 
(Caltag Laboratories). Class II was detected using mAb 7-16.17 
conjugated to biotin (PharMingen, San Diego, CA) followed by 
streptavidin-PE (SA-PE; Cahag Laboratories). CTLA4-Ig ligand 
was detected using 10 ~g/ml CTLA4-Ig fusion protein (27) fol- 
lowed by anti-human IgG-FITC (Tago Inc., Burllngame, CA). 
ICAM-1 was detected using mAb 3E2 conjugated to biotin (Phar- 
Mingen) followed by SA-PE. Staining for B220 used Ab RA3-6B2 
conjugated to either FITC or PE (Caltag Laboratories). 
Calcium Analysis. Calcium analysis was conducted essentially 
as described (24). Briefly, splenocytes were isolated, washed, and 
resuspended at 107 cells/ml in 10% FCS/RPMI and loaded with 
the calcium indicator Indo-lAM (1 #M, final concentration; Mo- 
lecular Probes, Inc., Eugene, OR) for 30 win at 37~ Cells were 
subsequently washed and stained with FITC-conjugated Abs to 
CD4 and CD8. Indo-1 loaded cells were suspended at5 x 106/rrd 
and prewarmed to 37~ immediately before analysis. Analysis was 
conducted at 37~ unstimulated ceils were collected for 45 s, Ag 
added at I min, and data collection continued for a total of 7 rain, 
with a flow rate of 200-400 cells/s. For mHEL stimulation (see 
Fig. 7 A) cells were collected for 45 s to establish basal calcium 
levels, cens removed, and mHEL-bearing or control thymocytes were 
added to a concentration of10Vml. The mixture was pelleted for 
5 s using a microfuge, resuspended using a micropipette, and data 
collection resumed. Thymocytes were excluded from analysis by 
electronically gating on Indo-1 loaded cells. CD4- or CDg-positive 
cells were excluded from analysis by electronic gating on FITC- 
negative cells. Detection of Indo-1 and FITC fluorescence used a 
dual hser FACStar Plus | flow cytometer (Becton Dickinson & Co.). 
Conversion of Indo-1 violet-blue fluorescence ratios to calcium levels 
was determined as described (28, 29). Transfer of Ig or Dbl- 
transgenic B cells into nontransgenic recipients was perforraed by 
intravenous injection of 107 spleen ceLls into 750 tad x-irradiated 
recipients. "Parked" cells were recovered from the spleen 36 h after 
transfer, loaded with Indo-1, and analyzed as described above. 
Pkospkotyrosine lmmunoblotting. For analysis of phosphotyrosine 
levels, freshly isolated sphnocytes were washed, resuspended at
107/ml in serum-free RPMI, and stimulated with the indicated re- 
agents for 5 rain at 37~ Cells were then pelleted, lysed, and ly- 
sates from 10 ~ cell equivalents were resolved on an 11% SDS- 
PAGE gel and immunoblotted with antiphosphotyrosine mAb 4(310 
(Upstate Biotechnology Inc., Lake Placid, NY) (final concentra- 
tion 1:2,000), using enhanced chemiluminescent detection as de- 
scribed previously (24). 
Results 
Tolerant B Cells Fail to Respond to T Cells Plus Ag. In 
previous experiments, self-reactive B cells from the lyso- 
zyme/anti-lysozyme Dbl-transgenic mice produced 10-50- 
fold less Ab than nontolerant B cells from Ig-transgenic mice 
lacking lysozyme, when assayed in cell transfer experiments 
after stimulation with Th cells primed to SRBC Ags and 
an antigenic onjugate of lysozyme and SRBC (20, 21, 30). 
The failure of self-reactive B cells from Dbl-transgenic mice 
to collaborate with SRBC-specific T cells could have reflected 
either a defect in their ability to take up and present lyso- 
zyme-SRBC Ag conjugates to Th cells, or a defect in the 
subsequent ability to interact with and receive growth and 
differentiation factors from T cells. To explore which of these 
steps was altered, the requirement for Ag binding and pro- 
cessing into MHC-associated peptides was bypassed by 
providing a constitutively expressed TCR-ligand on the B 
cells, using unique determinants on class II MHC molecules 
themsdves. B cells in C57BL/6 (]36) strain mice display I-A b 
MHC molecules that differ at three residues from I-A mole- 
cules in the coisogenic strain, bm12 (31). Because of this al- 
ldic difference, aproportion of Th calls in bin12 mice carry 
Ag receptors that are triggered by I-A b (Fig. 1 A; 31). Since 
I-A b molecules are displayed at normal evels on tolerant and 
nontolerant B ceils from B6 strain-transgenic mice (see Fig. 
2 A), successful collaboration between tolerant B6 B cells 
and bin12 Th cells would be expected if the B cell defect lay 
in the ability to take up and present Ags, but not if the defect 
lay dsewhere. 
Following the approach diagrammed in Fig. 1 A, spleen 
cells from B6 strain Dbl- and Ig-transgenic mice were marked 
with an alldic Ly5' cell surface marker and an IgM' Ig allo- 
type marker to allow unequivocal identification, and were 
transferred to recipient animals of the B6 strain. Spleen cells 
from bin12 mice, including anti I-A b Th cells, were cotrans- 
ferred in numbers determined to cause optimal B cell prolifer- 
ation and Ab production. In the absence of any cotransferred 
B cells, activation of the bm12-derived T cells occurred in 
response to I-A b radioresistant calls in the recipients, pro- 
ducing marked splenomegaly and other symptoms of GVHD 
within 5-7 d (data not shown). When bin12 T ceils and non- 
tolerant Ig-transgenic B cells were cotransferred into mice 
expressing lysozyme, the lysozyme-binding B cells were trans- 
formed into large blast cells (data not shown) and increased 
their numbers 10-50-fold (Fig. 1, B top right, and C top). 
The apparent proliferation of lysozyme-binding B cells was 
accompanied by differentiation i to Ab-secreting phsma ceUs, 
detected by ELISA-spot assay of spleen calls (Fig. 1 C, bottom). 
The presence of both lysozyme and I-AS-reactive T cells was 
required for proliferation and differentiation ofthe nontolerant 
lysozyme-binding B cells, since neither occurred when (a) 
the same cell mixtures were transferred into nontransgenic 
recipients lacking lysozyme (Fig. 1, B, top left, and C); or 
(b) Ig-transgenic cells were transferred to lysozyme-expressing 
mice without bm12 T cells (Fig. 2, A-C, top, and additional 
data not shown). By contrast with the response of nontolerant 
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Figure 1. In vivo collaboration between ontolerant or tolerant lysozyme-binding B cells expressing I-A b and l-Ab-specific helper T cells (TH) from 
bin12 strain mice. (.4) Experimental design to dissociate B cell Ag binding from T cell stimulation, using constitutively expressed I-Ab molecules to 
engage the TCK on bm12 Th cells. (B and C) LyS~-marked splenocytes from B6-LyS* Ig-transgenic (nontolerant; Ig/Ly5"), double-transgenic (tolerant; 
Dbl/Ly5"), or nontransgenic (Non/L?5=) mice were transferred with splenocytes from bin12 mice (plus T cell help) into irradiated B6-strain nontrans- 
genic mice (Non) or transgenic mice expressing soluble HEL (sHEL). 5 d after transfer, spleen cells were stained for HEL binding and LyS* expression 
and the frequency of positively stained cells measured by FACS ~ (B). The number of HEbbinding cells (C, top) and anti-HEL IgM* Ab-secreting 
cells (C, bottom) in the spleen of each recipient was determined. (Dots) The number of cells in individual recipients; (bars) arithmetic means. The data 
shown are from a single experiment and are representative of three independent experiments involving a total of 10 separate Ig- and 10 separate Dbl- 
transgenic donors. 
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Figure 2. Ag and bm12 Th ceils are both required for expansion and differentiation f nontolerant iysozyme-binding B cells, but remain unable 
to trigger tolerant B cells. (A-C) Equal numbers of Ig/Ly5 =+ and Dbl/Ly5=- splenocytes were mixed and transferred with B6-strain splenocytes (no 
T cell help) or bin12 splenocytes (plus T cell help) into irradiated nontransgenic or sHEl.-transgenic recipients. (A) 5 d after transfer, splenocytes were 
stained for HEL-binding and LyP expression to distinguish nontolerant (Ly5 ~+) from tolerant (Ly5,-) B cells. (B) The number of HEL-binding Ig/Ly5 -+ 
(open bars) or Dbl/Ly5'- (sappled bars) cells per spleen was determined for all the recipients. (C) Differentiation of B cells in the recipients was mea- 
sured in parallel by a third-color immunofluorescent stain for the plasma cell marker, syndecan, on HEL-binding Ig/Ly5 ,+ (solid line) or Dbl/Ly5,- 
(dashed line) B cells. Histograms were derived from threecolor analysis after gating on the HEL-binding Ly5 ~+ or Ly5'- cells shown in B. The data 
shown are from one experiment and are representative of three independent experiments involving a total of six separate Ig- and six separate Dbl- 
transgenic donors. (/9) Numbers of anti-HEL IgM~-secreting cells generated after 4 d in vitro culture of Ig- or Dbl-transgenic splenocytes with an 
excess of B6-strain and bm12-strain spleen cells (plus T cell help) or with lipopolysaccharide (LPS). Cultures were performed in the presence (+sHEL) 
or absence (-sHEL) of 100 ng/ml HEL. The experiment shown is representative of six independent in vitro culture experiments. 
cells, tolerant lysozyme-binding B cells from Dbl-transgenic 
mice showed little proliferation or Ab production in the pres- 
ence of both bm12 T cells and lysozyme (Fig. 1, B and C). 
To confirm that activated I-Ab-reactive Th cells were in- 
deed being generated in recipients of tolerant B cells, Dbl- 
and Ig-transgenic B cells were mixed and cotransferred with 
bm12 T cells into recipient animals. Nontolerant lysozyme- 
binding cells from the Ig-transgenic mice were in this case 
distinguished from tolerant Dbl-transgenic ells by the pres- 
ence of the Ly5 a allelic marker only on the former (e.g., Fig. 
2 A, top). Differentiation of lysozyme-binding Ly5 '+ (Ig- 
transgenic) or Ly5'- (Dbl-transgenic) cells into Ab-secreting 
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cells was measured inparallel by staining with an Ab to the 
plasma cell marker, syndecan (26 and Fig. 2 C). Nontolerant 
Ly5 "+ B ceils proliferated and differentiated fficiently in the 
presence of lysozyme and bml2 T cells (Fig. 2, A-C, bottom 
righ O, confirming that activated I-Ab-spedfic Th cells were 
indeed generated inthese recipients. By contrast, he tolerant 
Ly5'- B cells in the same hosts fared to undergo blastogen- 
esis, increase in cell number or differentiate into plasma cells 
(Fig. 2, A-C). 
The possibility that the tolerant B cells were capable of 
interacting with T ceils but failed to migrate to the appro- 
priate in vivo microenvironment was tested by performing 
equivalent experiments with bin12 T cells in suspension cul- 
tures in vitro. Small numbers of Ly5'-marked spleen cells 
from B6 Ig- or Dbl-transgenic mice were added to two-way 
mixed lymphocyte r actions between ontransgenic B6and 
bml2 spleen cells. Again, lysozyme-binding B cells from Ig- 
transgenic mice proliferated, as detected by blastogenesis and 
BrdU incorporation (data not shown) and differentiated into 
Ab-secreting ceils (Fig. 2/9) only when lysozyme was added 
to the cultures. Dbl-transgenic ceils, by contrast, showed little 
proliferation and generated 50-100-fold fewer Ab-secreting 
cells (Fig. 2 D and data not shown). Parallel cultures timu- 
lated with the nonspecific B cell mitogen, LPS, neverthdess 
confirmed that the tolerant B cells were potentially capable 
of efficient proliferation and differentiation i to Ab-secreting 
cells (Fig. 2 D, right columns) as previously described (32). 
Tolerant B Cells Respond to T Cell-derived Mediators. Two 
signals appeared necessary for efficient proliferation and dif- 
ferentiation of nontolerant lysozyme-binding B cells under 
the conditions of I-Ab-specific T cell help used above: one 
provided by the bin12 T cells, and one resulting from the 
binding of lysozyme to the B cell (see Fig. 1 A). Unrespon- 
siveness in the tolerant B cells could therefore have reflected 
a defective response to either of these signals. To test the re- 
sponse to T cell-derived signals, membrane fractions from 
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Figure 3. Response of tolerant and nonto[erant B cells to Th cells signals. (/I) +Immunonuorescent staining with CTLA4-[g to detect B7 and B7- 
related molecules (right) and class II MHC molecules (left) on Ig-transgenic (solid line) and Dbl-transgenic (~/m~ line) splenic B cells immediately after 
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The histosrams displayed are gated on B220 + ceils after e~cluding dead cells by staining with propidium iodide. (B and C) Proliferation of Ig-tramgenic 
(open circles) or Dbl-transgenic (filled circles) B ceils, assessed by pH]thymidine incorporation after stimulation with anti-CD40 (B) or anti-CD40 and 
IL-4 (C). Data displayed represent means of triplicate cultures and are representative of four independent experiments. 
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activated T cell hybridomas that contain CD40L (14, 33) were 
initially tested and found to trigger equivalent proliferation 
in tolerant and nontolerant B cells, and staining with Abs 
to CD40 showed equivalent expression on both types of B 
cells (data not shown). More specifically, treatment with a 
polyclonal ntiserum to recombinant mouse CD40 that mimics 
the action of membrane-bound CD40L (Heath, A. et al., 
manuscript submitted for publication), or stimulation with 
IL-4, each induced tolerant and nontolerant B cells to in- 
crease cell surface xpression ofdass II MHC (Fig. 3 A). Ad- 
ditionally, these stimuli also increased the immunofluores- 
cent staining of both cell types with CTLA4-Ig fusion protein 
(Fig. 3 A) which recognizes B7 and B7-related molecules ex- 
pressed on activated B cells (hereafter referred to CTLA4-Ig 
ligand; 34; see Discussion). Vigorous proliferation was in- 
duced in both cell types by antisera to CD40 (Fig. 3 B), and 
this was augmented in both tolerant and nontolerant B cells 
by addition of IL4 (Fig. 3 C). Taken together, these findings 
indicate that the tolerant B cells were fully responsive tokey 
signals mediating T cell help. 
Tolerant B Cells Do Not Respond to Ag. In contrast to the 
normal response to T cell-derived signals, many cellular re- 
sponses normally triggered by Ag binding to slg (for review 
see references 35 and 36) were absent in tolerant B cells. 
Binding of lysozyme at concentrations a  low as 1 ng/ml, 
which engages <5 % of the slg receptors (22), triggered vig- 
orous proliferation of nontolerant Ig-transgenic B cells in 
the presence of either IL-4 (Fig. 4 A), submitogenic concen- 
trations of LPS (Fig. 4 B), or suboptimal concentrations of 
anti-CD40 antiserum (data not shown). However, binding 
of lysozyme to tolerant B cells had no mitogenic effects in 
any of these assays (Figs. 4, A and B and not shown). Simi- 
larly, whereas binding of lysozyme alone was not mitogenic, 
it promoted activation of nontolerant Ig-transgenic B cells 
from Go to G: of the cell cycle, as assessed by increased RNA 
synthesis (Fig. 4 C) or by cell enlargement detected flow 
cytomerrically (dam not shown). In contrast, lysozyme binding 
failed to induce cell enlargement or increased RNA synthesis 
in tolerant B cells (Fig. 4 C, and data not shown). Finally, 
lysozyrne binding triggered increased expression ofCTLA4-Ig 
ligand and ICAM-1 molecules on nontolerant Ig-transgenic 
cells, but induced little increase in the expression of these 
molecules on tolerant Dbl-transgenic cells (Fig. 4 D). 
The absence of many cellular esponses to Ag binding in 
the tolerant cells was further explored by following early signal- 
transduction events normally triggered by sIg engagement. 
One of the earliest biochemical events, an increase in the level 
of intracellular calcium ([Ca]i; 35, 36), was measured by 
four-color flow cytometry after loading spleen cells with the 
calcium indicator, Indo-1. Binding of lysozyme to receptors 
on nontolerant Ig-transgenic B cells induced arapid rise in 
the level of [Ca]i that peaked within 1 rain and included 
nearly all of the HEL-specific B cells (Fig. 5 A). By contrast, 
stimulation of tolerant Dbl-transgenic B cells with a range 
of concentrations of lysozyme from 20 to 500 ng/ml failed 
to induce a detectable increase in [Ca]i (Fig. 5 A, and data 
not shown). Activation of protein tyrosine kinases is an inte- 
gral event in signal transduction byslg that lies immediately 
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Figure 4. Early cellular esponses after Ag binding to 
tolerant and nontolerant B cells. (A) Proliferation of 13 
cells from Ig-rtansgenic (open symbo/~) orDbl-ttansgenic 
(fil/ed s,/mbo/s) mice as measured by [3H]thymidine incor- 
potation after 48 h of culture with the indicated amounts 
of HEL in the presence of IL-4. (B) Proliferation i  re- 
sponse to HEL in the presence of submitogenic concen- 
ttafions of LPS (1/~g/znl). For comparison, square symbols 
show proliferation to optimal concentrations of LPS (20 
~tg/ml). ((3) Transition from Go to G1 of the cell cycle 
as measured by incorpotarion of [3H]uridine into cellular 
RNA in response to the indicated concentrations ofHEL. 
(D) Expression of CTLA4-Ig ligand and ICAM-1 after 
Ag stimulation of Ig-ttansgenic (solid line) or Dbl- 
transgenic (dotted line) B cells after 12 h (CTLA4-Ig) or 
24 h (ICAM-1) of culture with 100 ng/ml lysozyme 
(bottom) or medium alone (to/,). 
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Figure 5. Signaling events triggered by HEL-binding in tolerant and 
nontolerant B cells. (,4) Intracellular calcium levds as a function of time 
in freshly isolated Ig- or Dbi-transgt'nic splenic B cells before and after 
the addition of lysozyme (arrows). (Inset) Rehtive number of free HEL 
binding sites on Ig (solid line)- or Dbl (dotted line)- transgenic B cells before 
stimulation, as detected using fluorescently hbded HEL. (B) Intracellular 
calcium levels of Ig- or Dbl-tramgenic B cells that had been parked in
nontransgenic mice for 36 h before harvesting and in vitro simulation with 
HEL (arrows). Note (inset) that the number of available HEbbinding sites 
is nearly identical onparked Ig- and Dbl-transgenic B cells. (C) Anti- 
phosphotyrosine immunoblottlng, showing induction of phosphotyrosine- 
containing proteins 5 min after addition of lysozyme to nontransgenic, 
Ig-tnusgenic, and Dbl-trausgenic spleen cells. Notethat the reduced level 
of phosphotyrosine-containing proteins in unstimulatcd nontr nsg~c cells 
(lane I) and in Dbl-transgenic cells stimulate~i with 400 ng/ml HEL (lane 
15) results from poor transfer and is not representative (see Fig. 6 A). 
upstream to the initiation of increased [Ca]i (37-40). To 
measure tyrosine kinase activation, Dbl- and Ig-transgenic 
spleen cells were stimulated with lysozyme in vitro, and cell 
lysates were then prepared and probed by immunoblot using 
Abs specific for phosphotyrosine. Lysates fromunstimulated 
tolerant or nontolerant cells had few phosphotyrosine-con- 
tainiug proteins (Fig. 5 C). Stimulation with concentrations 
of lysozyme as low as 6 ug/ml resulted in rapid appearance 
of many phosphotyrosine-containing proteins within the non- 
tolerant Ig-transgenic B cells. By contrast, even saturating 
concentrations of lysozyme failed to induce a detectable in- 
crease in phosphotyrosine species in the tolerant B cells (Fig. 
5C). 
Because of modulation of IgM Ag receptors and in vivo 
occupancy ofmany IgD receptors with lysozyme, B cells from 
the Dbl-transgenic mice display 3-4-fold fewer available 
receptors for binding additional exogenous lysozyme mole- 
cules than nontolerant B cells from Ig-transgenic mice (Fig. 
5 A inset). To test whether the signaling defects in the Dbl- 
transgenic B cells were simply a result of fewer receptors, 
or alternatively, a short-term refractory phenomenon due to 
recent in vivo exposure to lysozyme, B ceils were removed 
from the Dbl-transgenic mice and "parked" in irradiated non- 
transgenic mice to allow bound lysozyme to dissociate. 36 h 
after transfer, the parked Dbl-transgenic B calls displayed a 
nearly equivalent capacity to bind fluorescently labeled lyso- 
zyme as did parked Ig-transgenic B ceils (Fig. 5 B, inset). 
Despite this, the tolerant ceils remained unable to increase 
[Ca]i after stimulation with lysozyme (Fig. 5 B), indicating 
that the defect in signaling was not due simply to receptor 
modulation. Whereas [Ca]i increase is an immediate conse- 
quence of tyrosine kinase activation (37-40), parked B calls 
could not be recovered in suflfident umbers or purity to mea- 
sure protein tyrosine phosphoryhtion directly. 
Defective Response of Tolerant B Cells to anti-IgD Abs. The 
absence of intracellular signaling events after HEL binding 
to tolerant B cells was fimher egplored by stimulating tolerant 
and nontolerant B ceils with affinity-purified Abs to the C 
regions of IgD. Stimulation by anti-IgD differed from lyso- 
zyme stimulation in that IgD is expressed at identical levels 
on tolerant and nontolerant B cells, is equally accessible to 
anti-C region Abs, and thexefore should be cross-linked equally 
weU on the two cell types. Additionally, thepolydonal anti- 
IgD Abs should promote xtensive receptor cross-linking and 
therefore would test whether tolerant B ceils retained any 
capacity to signal through sIg. In contrast to stimulation with 
lysozyme, extensive cross-l/nking of sI D receptors elicited 
some early signaling events i  he tolerant B cells, although 
the magnitude and kinetics of the response remained altered 
compared with nontolerant B cells. Thus, treatment with 
anti-IgD antisera induced an identical pattern of phospho- 
tyrosine-containiug proteins in both Dbl- and Ig-transgenic 
B cells, although the rdative abundance of labeled proteins 
was markedly reduced in tolerant cells (Fig. 6 A). Similarly, 
anti-IgD stimulation triggered a prolonged increase in [Ca]i 
in nontolerant Ig-transgenic ceils, with the fraction of B ceils 
containing micromolar concentrations of [Call remaining at 
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Figure 6. IL~ponse of tolerant and nontolerant B cells to receptor c oss- 
linking by polyclonal anti-IgD Abs. (A) Phosphotyrosine-containing cel- 
lular proteins 5 min after stimulation oflg-, Dbl-, or non-transgenic spleno- 
cytes with media (0), 10/~g/ml goat anti-IgM Abs (IgM), 10/~g/ml goat 
anti-IgD Abs (IgD), or 100 ng/ml HEL (HEL). Note that the prominent 
32- and 33-kD phosphotyrosine pecies induced by anti-IgM and anti- 
IgD, respectively, are likely to represent the Ig-associated molecules IgM(x 
and IgDol (77). (B) Intracellular calcium levels after stimulation f Ig- 
and Dbl-transgenic B ells with goat anti-IgD Abs (10/~g/ml). (C) Acti- 
vation from Go to Gt of the cell cycle, as measured by [3H]uridine incor- 
poration induced by goat anti-IgD stimulation of Ig (open symbols)- and 
Dbl (filled syrabols)-transgenic splenocytes. (D) Proliferation of Ig (open 
symbols)- and Dbl (filled symbols)-transgenic B cells induced by goat anti- 
IgD in the presence of submitogenic concentrations of LPS (1 /~g/ml). 
(E) Mitogenic response of Ig (open bors)- and Dbl (filled bars)-transgenic 
B cells after stimulation with media alone (0), Ionomycin (1 #g/ml), and 
PMA (1 ng/ml) (I/P) or LPS (20/~g/ml). (F) Induction of CTLA4-Ig 
ligand on Ig (solid line)- and Dbl (dotted llne)- transgenic B cells 12 h after 
stimulation with goat anti-IgD (10/~g/ml). 
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10-15% for up to 4 min (Fig. 6 B, left). In contrast, stimula- 
tion of tolerant B cells with anti-IgD induced a more rapid 
initial [Ca]i response, but this response diminished much 
more quickly and lacked the sustained phase observed in the 
nontolerant B cells (Fig. 6 B, right). 
Whereas the ability of anti-IgD antisera to evoke prox- 
imal signaling events uggested that the necessary receptor- 
associated components were at least partially present and ac- 
tivatable in the tolerant B cells, more distal events such as 
cell cycle entry still failed to occur. Thus, stimulation with 
the same antiolgD antiserum failed to trigger G0-G1 transi- 
tion in Dbl-transgenic cells as measured by induction of RNA 
synthesis (Fig. 6 C), and promoted little DNA synthesis in 
the tolerant cells in combination with submitogenic concen- 
trations of LPS (Fig. 6 D). Similar results were obtained with 
mAbs to IgD coupled to dextran (41), which also cross-link 
Ig receptors extensively and promoted vigorous proliferation 
in the nontolerant Ig-transgenic B cells, but induced little 
or no mitogenic response in tolerant B cells (data not shown). 
Proliferation in response to calcium ionophore and phorbol 
ester, which bypass the requirement for slg signaling, remained 
intact in the tolerant cells (Fig. 6 E). Whereas extensive 
receptor cross-linking with anti-IgD Abs was unable to pro- 
mote cell cycle entry, this stimulus was nevertheless ufficient 
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to induce high expression ofCTLA4-Ig ligand on the tolerant 
calls (Fig. 6 F). 
Tolerant B Cells Respond toMembrane-bound Lysozyma Since 
early signaling events could be partially restored and CTLA4-Ig 
ligand induced on the tolerant B cells after extensive receptor 
cross-linking with Abs to IgD, we tested whether ahighly 
multivalent form of lysozyme xpressed on ceU surfaces as 
an integral membrane protein (mHEL) would also restore 
sIg signal transduction. Thymocytes from transgenic mice 
expressing mHEL on cell surfaces (21) were therefore mixed 
with Indo-1 loaded B cells and changes in [Call measured 
as previously. In contrast to stimulation with soluble lyso- 
zyme which remained unable to dicit a [Call response in 
tolerant B calls (Fig. 7 A, 2), stimulation with membrane 
lysozyme triggered a dear [Call response in both tolerant- 
and nontolerant-transgenic B cells although the response in 
the latter was somewhat weaker (Fig. 7 A, 7 and 8). Control 
B6 thymocytes lacking mHEL elicited no response in either 
cell type (Fig. 7 A, 3 and 4). Combined stimulation with 
control B6 thymocytes and soluble HEL remained unable to 
dicit a calcium response in tolerant B cells (Fig. 7 R, 6), in- 
dicating that Ag display on membranes was required and that 
costimulatory molecules on thymocytes were not sufficient. 
To test whether the partial restoration ofsIg signaling in- 
duced by displaying lysozyme in multimeric cell-bound form 
was sufficient o restore collaboration with I-Ab-specific Th 
cells, transgenic B cells, and bm12 T cells were transferred 
into recipient mice expressing mHEL. Tolerant B cells from 
Dbl-transgenic mice remained poorly responsive to soluble 
lysozyme (sHEL) and bm12 helper calls (Fig. 7, B and C, 
middle columns), but their helper ceil-induced proliferation 
and differentiation i to Ab-secreting plasma cells increased 
100-fold in recipients expressing mHEL (Fig. 7, B and C, 
right columns). The magnitude of the response mounted by 
tolerant B cells in the presence of mHEL was equivalent to 
that mounted by nontolerant Ig-transgenic B cells in the pres- 
ence of sHEL, and only fivefold less than the response of the 
latter in mHEL recipients (Fig. 7, B and C). Thus, display 
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Figure 7. Membrane-bound lysozyme can trigger slg signaling in tolerant B cells and promote ffective collaboration with I-Ab-specific helper T 
cells. (A) Intracellular calcium levels in Ig (/eft)- and Dbl (r~ghO-transgenic B cells after stimulation with soluble HEL (1 and 2), B6 thymocytes (3
and 4), B6 thymocytes plus soluble HEL (5 and 6), or thymocytes bearing membrane-bound lysozyme (mHEL; 7 and 8). At the arrow, B calls were 
removed and stimulated as indicated (see Materials and Methods for details). (B and C) In vivo collaboration between Ig- and Dbl-transgenic B cells 
and bm12 Th ceils. (B) Enumeration of HEbbinding B cells and (C) numbers of anti-HEL-specific plasma cells was determined as in Fig. 1, after 
transfer of Ig-transgenic (open Mrs) or Dbbtransgenic (filled bars) splenocytes with bm12 splenocytes into irradiated B6 strain mice (Non), or into trans- 
genie mice expressing sohble lysozyme (sHEL) or membrane-bound lysozyme (mHEL). Shown are the arithmetic averages (bars) and individual values 
(dots) for cells from three separate Ig- or Dbl-transgenic donors. The experiment shown is representative of three independent experiments involving 
seven separate Ig- and seven separate Dbl-transgenic donors. 
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of membrane-bound Ag could partially restore slg signaling 
in tolerant B cells and effective collaboration with I-A b- 
specific Th cells. 
Discussion 
The studies above localize the molecular mechanism ac- 
counting for B cell clonal anergy to a proximal step in the 
sIg signal transduction pathway. Moreover, the findings in- 
dicate that Ag-specific B cells require signals from T cells 
and from Ag binding to sIg for efficient proliferation and 
differentiation into Ab-secreting cells, as originally proposed 
by Bretscher and Cohn (42). The conclusion that Ag-derived 
signals through sIg are required was based on three observa- 
tions: (a) in the presence of activated I-Ab-reactive T cells, 
nontolerant, lysozyme-specific B cells expressing bA h made 
no Ab response unless they were also exposed to antigen; 
(b) under the same conditions, tolerant, lysozyme-spedfic B 
cells failed to respond even when exposed to lysozyme, and 
these cells lacked lysozyme-induced sIgsignaling; (c) a more 
potent multivalent form of lysozyrrle, membrane lysozyme, 
was able to trigger some signaling through sIg in tolerant 
cells, and this markedly restored their ability to mount an 
Ab response in the presence of activated Th cells. 
Basis for Blocked Signaling in Tolerant B Cells. The absence 
of slg signaling after Ag binding to the tolerant B cells could 
in principle reflect either a biochemical b ock in signal trans- 
duction or simply the presence of fewer available receptors 
on the Dbl-transgenic B cells. Three findings establish that 
the latter cannot account for the signaling defect. Firstly, the 
tolerant B cells display 30% of the number of available HEL- 
binding receptors on nontolerant B cells, yet failed to respond 
to any concentration f HEL in assays where nontolerant B 
cells responded optimally to concentrations that engage <5% 
of available receptors (Figs. 3, B and C, and 4 C). Second, 
Dbl-transgenic B cells that had been parked in nontransgenic 
mice and that had recovered comparable HEL-binding ca- 
pacity remained unable to increase [Call after HEL binding 
(Fig. 4 B). Third, IgD receptors are expressed at identical 
levels on tolerant and nontolerant B cells and should be cross- 
linked identically after treatment with polydonal antisera to 
IgD or anti-IgD coupled to dextran. These stimuli neverthe- 
less elicited markedly reduced proximal signaling and failed 
to induce mitogenesis in tolerant B cells (Fig. 5 C and D, 
and data not shown). 
Given the evidence for a signaling block, the failure of anti- 
IgD stimulation to induce G0-G1 transition or cell cycle 
entry in the tolerant B cells despite activating some tyrosine 
phosphorylation a d calcium influx (Fig. 5), could have im- 
plied a block downstream of these initial events. The fact 
that the tolerant B cells proliferated normally after stimula- 
tion with calcium ionophore and phorbol ester (Fig. 6 E) 
nevertheless argues against adownstream defect. Moreover, 
the short-lived calcium response induced by anti-IgD in the 
tolerant cells (Fig. 6 A) is most consistent with a receptor- 
proximal defect, since coupling of [Call stores to cellular 
influx, as assessed by exposure to thapsigargin occurs nor- 
mally in the tolerant B cells (Cooke, M.P., unpublished ob- 
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servations). Sustained Ag receptor signaling is necessary for 
activation of both B (43) and T cells. Removal or blocking 
of TCR stimuli any time during the first 2 h of stimulation 
blocks early cellular responses such as IL-2 gene induction 
(44) and similarly, removal of anti-IgM Abs any time during 
the first 16 h of B cell stimulation effectively halts cell cycle 
progression (45). Indeed, the lack of response to weak stimuli 
(sHEL) and transient responses to strong stimuli (polyclonal 
anti-IgD) resembles the response to different anti-TCR Abs 
in mutant T cell lymphomas that lack a single component 
of the TCR signal-transduction c mplex, such as the tyro- 
sine kinase p56 ~k (46). 
Exactly how Ag binding induces lg signaling remains to 
be fully elucidated, although Ag-driven receptor dimeriza- 
tion or multimerization is thought to play an important role 
(for a review see reference 47). The ability of sHEL to trigger 
slg signaling is in this respect surprising, since sHEL is known 
to bind the transgene-encoded Ig as a monomer (48). Many 
of the signaling events induced by sHEL (Figs. 4 and 5) 
nevertheless appear equivalent to those described for nonmito- 
genic monoclonal IgG Abs to IgM or IgD (for reviews ee 
references 35 and 36). We therefore favor the view that sHEL, 
like anti-Ig Abs, induces lg signaling by receptor dimeriza- 
tion. HEL-mediated dimerization could occur via preformed 
HEL dimers in solution or be driven by high local concen- 
trations of receptor-bound HEL on the cell surface, since HEL 
dimerizes in solution at higher concentrations (49). By com- 
parison, the ability of polyvaleut ligands uch as polyclonal 
anti-IgD and membrane-bound HEL to partially overcome 
the sHEL-induced signaling blockade may simply reflect more 
extensive slg multimerization induced by these ligands. Con- 
sistent with this notion, increasing the valency of initially 
oligovalent Ags or divalent anti-Ig Abs has been found to 
markedly increase their potency for B cell activation (39, 50). 
Since other B cell surface proteins uch as CD19, CD21 
(for reviews ee references 51 and 52), and CD22 (53) may 
also participate in signaling by slg, it will be important to 
determine whether differences in their activity may contribute 
to the sIg signaling defect found in tolerant B cells. It will 
also be important to relate the regulation of sIg signaling 
in tolerant B cells to the interruption of sIg signaling in- 
duced in mature B cells by acute sIg cross-linking (54, 55) 
or by coligation with the Fc~ receptor (56, 57), particularly 
since the latter is thought o provide an important negative 
feedback during Ab responses to foreign Ags (for a review 
see reference 58). 
Role of slg Signaling in B-T Cell Interaction. Whereas the 
role of slg in mediating Ag uptake for subsequent processing 
and presentation to Th cells is well established (9-12), the 
role of slg signal transduction i T cell-dependent Ab re- 
sponses has remained unclear (59-62). In particular, it is 
difficult to reconcile the need for both MHC-restricted B cell 
Ag presentation a d the need for slg signaling with recent 
studies demonstrating that, in the absence of both events, 
membrane CD40L together with T cell-derived lymphokines 
can nevertheless trigger esting B cells to proliferate and pro- 
duce Ab efficiently (for a review see reference 7). 
A model to explain the requirement for sIg signaling and 
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Figure 8. A model to explain the requirement for slg signaling and 
MHC-restricted antigen presentation during B-T cell interactions. The 
model assumes that CD40L and Ib4 are transiently expressed during Th 
cell activation, and must be teinduced during each B-T cell interaction. 
Reinduction fthese growth and differentiation factors during B-T cell 
synapsis i hypothesized to require the T cell m be stimulated both by 
antigen peptide-MHC complexes ngaging the TCK and by B cell activa- 
tion molecules such as B7 engaging CD28, or other activation molecules 
(X) engaging receptor (R-X). T cell help is thus delivered s ectively to
B cells that make Abs specific for foreign Ags, since only in these cells 
does the binding of Ag to slg allow both eificient uptake of Ag for presen- 
tation and trigger expression f B7 and other activation markers. 
MHC-restricted Ag presentation i T cell-dependent Ab 
production is outlined in Hg. 8. The model assumes that 
T cell expression of CD40L after activation is transient, as 
has been shown in vitro (2), requiring that CD40L be rein- 
duced during T-B cell synapsis. Surface Ig on Ag-specific B 
cells may thus play two roles in reinducing CD40L, firstly 
by capturing Ag for effident processing and presentation to
the TCK and second by triggering a marked increase in B 
ceil activation molecules uch as B7 on the cell surface (63, 
and Fig. 3). Other activation molecules triggered by slg sig- 
haling after Ag binding, simply denoted "X" in Fig. 8, in- 
dude ICAM-1, (64, and Fig. 4 D), CD44 (65, 66), and LFA-1 
(64). The combined presence of specific peptide-MHC com- 
plexes and certain activation molecules on the B cell may be 
required to reinduce CD40L expression and other Th ceil 
functions. In support of this notion, B7 signaling through 
CD28 on the T cell is strongly synergistic with TCK sig- 
naling for restimulating T cell production of IL-2 (27, 6%71) 
and for stimulating re-expression f CD40L (Clark, E., per- 
sonal communication). 
While the importance of CD28 costimulation during in- 
teraction between B ceils and T calls remains to be estab- 
lished, several lines of evidence suggest apivotal role. In ex- 
periments here, induction of B7 or B7-related molecules on 
Ag-binding B cells correlated with their ability to mount 
an Ab response in the presence of activated I-Ab-specific T
cells. Conversely, primary T ceil-dependent Ab responses in
mice have been shown to be suppressed by blocking B7 or 
B7-rdated molecules with soluble CTLA4-Ig (72, 73). Simi- 
larly, gene knockout mice lacking the CD28 receptor for B7 
have greatly diminished T cell-dependent Ab responses but 
apparently normal cytotoxic and delayed-type hypersensitivity 
T cell responses (74). 
Based on the above, it willbe important to determine what 
effect is induced in Th ceils when bound Ag is presented by 
tolerant B cells that fail to signal through sIg and lack 
costimulatory molecules such as B7. We have recently estab- 
lished that tolerant Dbl-transgenic B cells do indeed process 
and present lysozyme fficiently to lysozyme-speciiic T eils 
from a TCR gene transgenic mouse (Ho, W., M. M. Davis, 
M. P. Cooke, and C. C. Goodnow, unpublished observa- 
tions). In contrast to presentation ofAg by nontolerant Ig- 
transgenic B cells, however, the tolerant B cells fail to trigger 
T cell effector functions in vitro unless e~ogenous anti-CD28 
Ab is provided, and the tolerant B cells still fail to be induced 
into proliferation or Ab production i  vitro and in vivo. Since 
TCR signaling in the absence of costimulation through CD28 
results in T cell anergy under some conditions (for reviews 
see references 75 and 76), it will be important to determine 
whether antigen presentation by tolerant B cells is neutral 
or has an active negative ffect on Th cell function. 
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